Research and Development Expense (TTM) Chart

Historical Research and Development Expense (TTM) Data

View and export this data back to 2023. Start Trial.
Date Value
September 30, 2026 183.98M
June 30, 2026 186.05M
March 31, 2026 185.25M
December 31, 2025 188.30M
September 30, 2025 192.80M
June 30, 2025 215.17M
March 31, 2025 262.74M
Date Value
December 31, 2024 313.30M
September 30, 2024 348.42M
June 30, 2024 359.98M
March 31, 2024 354.50M
December 31, 2023 338.74M
September 30, 2023 301.03M
June 30, 2023 257.25M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Moderna, Inc. 2.401B
Twist Bioscience Corp. 71.84M
Prime Medicine, Inc. 136.33M
Kailera Therapeutics, Inc. 283.60M
Oncolytics Biotech, Inc. 13.18M